Wells Fargo’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.3K Hold
17,937
﹤0.01% 5656
2025
Q4
$30K Sell
17,937
-10,214
-36% -$17.7K ﹤0.01% 5686
2025
Q3
$47.6K Buy
28,151
+324
+1% +$383 ﹤0.01% 5567
2025
Q2
$25.3K Sell
27,827
-85,619
-75% -$50.8K ﹤0.01% 5728
2025
Q1
$51.2K Buy
113,446
+18,552
+20% +$10.9K ﹤0.01% 5388
2024
Q4
$47.7K Buy
94,894
+23,527
+33% +$17.3K ﹤0.01% 5503
2024
Q3
$64.6K Buy
71,367
+3,926
+6% +$3.64K ﹤0.01% 5253
2024
Q2
$67.3K Buy
67,441
+7,065
+12% +$7.8K ﹤0.01% 5163
2024
Q1
$89.4K Sell
60,376
-579
-0.9% -$656 ﹤0.01% 4956
2023
Q4
$66.4K Buy
60,955
+8,783
+17% +$9.62K ﹤0.01% 5150
2023
Q3
$61.6K Sell
52,172
-27,687
-35% -$37.7K ﹤0.01% 5072
2023
Q2
$113K Buy
79,859
+52,963
+197% +$73.2K ﹤0.01% 4965
2023
Q1
$40.3K Sell
26,896
-54
-0.2% -$75 ﹤0.01% 5278
2022
Q4
$31.5K Buy
26,950
+21,443
+389% +$27K ﹤0.01% 5071
2022
Q3
$6K Sell
5,507
-2,998
-35% -$4.4K ﹤0.01% 5858
2022
Q2
$13K Sell
8,505
-194,505
-96% -$256K ﹤0.01% 5644
2022
Q1
$312K Sell
203,010
-321,831
-61% -$499K ﹤0.01% 4721
2021
Q4
$1.29M Sell
524,841
-179,603
-25% -$420K ﹤0.01% 3900
2021
Q3
$1.78M Buy
704,444
+693,901
+6,582% +$1.78M ﹤0.01% 3768
2021
Q2
$30K Buy
10,543
+910
+9% +$2.35K ﹤0.01% 5758
2021
Q1
$22K Sell
9,633
-121,689
-93% -$292K ﹤0.01% 6118
2020
Q4
$231K Buy
131,322
+2,086
+2% +$2.92K ﹤0.01% 5006
2020
Q3
$121K Sell
129,236
-25,865
-17% -$22.8K ﹤0.01% 5182
2020
Q2
$135K Sell
155,101
-145,270
-48% -$128K ﹤0.01% 5086
2020
Q1
$249K Buy
300,371
+118,418
+65% +$118K ﹤0.01% 4541
2019
Q4
$162K Buy
181,953
+131,147
+258% +$109K ﹤0.01% 5076
2019
Q3
$50K Buy
50,806
+3,589
+8% +$3.72K ﹤0.01% 5557
2019
Q2
$52K Sell
47,217
-7,791
-14% -$8.98K ﹤0.01% 5537
2019
Q1
$73K Sell
55,008
-4,780
-8% -$5.95K ﹤0.01% 5226
2018
Q4
$55K Sell
59,788
-3,199
-5% -$4.9K ﹤0.01% 5485
2018
Q3
$130K Buy
62,987
+3,878
+7% +$8.15K ﹤0.01% 5231
2018
Q2
$106K Sell
59,109
-102,404
-63% -$206K ﹤0.01% 5352
2018
Q1
$380K Buy
161,513
+2,921
+2% +$6.85K ﹤0.01% 4594
2017
Q4
$298K Buy
158,592
+35,950
+29% +$78.5K ﹤0.01% 4754
2017
Q3
$304K Buy
122,642
+34,437
+39% +$85.4K ﹤0.01% 4667
2017
Q2
$243K Buy
88,205
+1,894
+2% +$5.29K ﹤0.01% 4662
2017
Q1
$260K Sell
86,311
-1,265
-1% -$3.59K ﹤0.01% 4651
2016
Q4
$277K Buy
87,576
+27,372
+45% +$84K ﹤0.01% 4585
2016
Q3
$206K Buy
60,204
+33,947
+129% +$93.8K ﹤0.01% 4470
2016
Q2
$61K Sell
26,257
-10,325
-28% -$25.3K ﹤0.01% 5118
2016
Q1
$93K Sell
36,582
-8,368
-19% -$18.7K ﹤0.01% 4882
2015
Q4
$149K Sell
44,950
-855
-2% -$2.56K ﹤0.01% 4644
2015
Q3
$112K Buy
45,805
+12,997
+40% +$33.6K ﹤0.01% 4803
2015
Q2
$96K Buy
32,808
+25,224
+333% +$97.8K ﹤0.01% 5078
2015
Q1
$31K Buy
7,584
+2,363
+45% +$8.18K ﹤0.01% 5208
2014
Q4
$16K Sell
5,221
-3,567
-41% -$9.64K ﹤0.01% 5453
2014
Q3
$22K Sell
8,788
-2,190
-20% -$5.27K ﹤0.01% 5254
2014
Q2
$27K Buy
10,978
+6,425
+141% +$14.5K ﹤0.01% 5232
2014
Q1
$12K Sell
4,553
-806
-15% -$2.37K ﹤0.01% 5356
2013
Q4
$15K Buy
5,359
+403
+8% +$1.22K ﹤0.01% 5088
2013
Q3
$15K Hold
4,956
﹤0.01% 5032
2013
Q2
$16K Buy
+4,956
New +$15.9K ﹤0.01% 4936

Other funds holding LCTX